For millions of people with migraine, finding effective relief can be a frustrating journey marked by trial and error with various therapies. Hope may be on the ...

When you buy through links on our articles, Future and its syndication partners may earn a commission. A GLP-1 agonist, the same class of drugs as Ozempic, may treat migraine, a study finds. | Credit: ...

Share on Pinterest Can a GLP-1 drug help protect against cognitive decline? Early trials say ‘yes.’ Image credit: Halfpoint Images/Getty Images. Over the last year, the use of and interest in glucagon ...

Our easy-to-read fact sheet provides clinicians with an overview of the mechanism of GLP-1 agonists. Our easy-to-read fact sheets provide clinicians with reliable information to share with patients ...

New research reveals that liraglutide, a GLP-1 receptor agonist, crosses the blood-brain barrier to target specific neurons, reducing appetite and promoting lasting weight loss. Liraglutide, a ...

A current weight-loss and diabetes drug has become a surprise candidate for migraine treatment, with a new pilot study showing the GLP-1 receptor agonist provided significant relief to sufferers of ...

PHILADELPHIA -- A GLP-1 receptor agonist may have the ability to protect cognition in people with mild Alzheimer's dementia, data from the phase IIb ELAD trial suggested. Liraglutide (Saxenda, Victoza ...

Liraglutide (Victoza), a type 2 diabetes drug, may help prevent peripheral artery disease (PAD) progression, the small, open-label STARDUST trial suggested. Over 6 months, adults with type 2 diabetes ...

Future research will focus on potential mechanisms of how GLP-1R agonists are improving insulin sensitivity independent of weight loss." Eighty-eight individuals with obesity and pre-diabetes were ...

A new study demonstrates that a glucagon-like peptide-1 receptor (GLP-1R) agonist, a member of a class of medication used to treat Type 2 diabetes and obesity, can lead to a rapid improvement in ...